ETFs
G
GRI
GRI Bio
2.880
+0.590+25.76%After Hours: 2.625 -0.255 -8.87%19:58 09/04 EDT
OPEN/PREV CLOSE2.340/2.290
TODAY RANGE2.330-3.360
VOL7.46M
MARKET CAP6.30M
52 WEEK RANGE1.360-80.36
AVG VOL (3M)330.88K
% TURNOVER332.46%
TURNOVER--
P/E (TTM)-0.0558
% RANGE44.98%
EPS(TTM)-51.6532
P/E(FORWARD)-0.6973
P/B0.6125
BVPS4.702
DIVIDEND--
P/S476.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.27M
SHARES OUTSTANDING2.19M
NEXT EARNINGS11/12-11/16
FREE FLOAT2.18M
LOT SIZE1
EX-DATE01/26/2026
News
Press Releases
Financial Reports
Profile
Benzinga·16h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·08/24 09:54
GRI Bio Is Maintained at Buy by Ascendiant Capital
Dow Jones·08/24 09:54
GRI Bio Price Target Cut to $27.00/Share From $32.00 by Ascendiant Capital
Benzinga·08/11 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·07/20 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·06/18 23:11
GRI Bio Secures FDA Orphan Drug Status for IPF
TipRanks·06/18 13:05
GRI Bio announces U.S. FDA granted ODD to GRI-0621
TipRanks·06/17 15:00
GRI Bio granted FDA orphan designation for tazarotene
TipRanks·06/03 12:44
GRI Bio (GRI) Gets a Buy from Ascendiant
Benzinga·06/01 12:43
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Dow Jones·06/01 10:38
GRI Bio Is Maintained at Buy by Ascendiant Capital
Dow Jones·06/01 10:38
GRI Bio Price Target Cut to $32.00/Share From $40.00 by Ascendiant Capital
Benzinga·06/01 10:28
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $32
Same Industry
Name/Symbol
Change%
Price